Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-05-27 @ 6:55 PM
Study NCT ID:
NCT06016920
Status:
RECRUITING
Last Update Posted:
2024-12-17
First Post:
2023-08-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma
Sponsor:
Nykode Therapeutics ASA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VB-C-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |